Finance

Lists
1795:TPE
Lotus Pharmaceutical Co Ltd
180,50 TWD
-1,10%
(-2,00) 1D
8-окт., 13:30:08 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1795...
Open
182,50 TWD
High
182,50 TWD
Low
179,50 TWD
Mkt. cap
48,76 млд
Avg. vol.
761,43 миң
Volume
588,14 миң
Dividend
1,40%
Quarterly dividend
0,63 TWD
Ex-dividend date
2026-ж., 31-авг.
P/E ratio
12,75
52-wk high
364,76 TWD
52-wk low
168,31 TWD
EPS
14,16 TWD
No. of employees
1 миң
Open
182,50 TWD
High
182,50 TWD
Low
179,50 TWD
Mkt. cap
48,76 млд
Avg. vol.
761,43 миң
Volume
588,14 миң
Dividend
1,40%
Quarterly dividend
0,63 TWD
Ex-dividend date
2026-ж., 31-авг.
P/E ratio
12,75
52-wk high
364,76 TWD
52-wk low
168,31 TWD
EPS
14,16 TWD
No. of employees
1 миң
News stories
From web sources and news partners
About Lotus Pharmaceutical Co Ltd
CEOPetar Vazharov
Employees1,1 миң
Founded1966
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
4,77 млд
6,26 млд
8,64 млд
8,81 млд
Cost of goods sold
2,04 млд
2,80 млд
4,26 млд
4,08 млд
Cost of revenue
2,04 млд
2,80 млд
4,26 млд
4,08 млд
Research and development expenses
447,99 млн
-33,26 млн
279,59 млн
246,02 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,10 млд
1,70 млд
2,14 млд
2,15 млд
Operating expense
1,54 млд
1,67 млд
2,43 млд
2,40 млд
Total operating expenses
3,58 млд
4,47 млд
6,69 млд
6,48 млд
Operating income
1,19 млд
1,80 млд
1,96 млд
2,33 млд
Other non operating income
-35,38 млн
22,65 млн
111,63 млн
-130,53 млн
EBT including unusual items
1,83 млд
1,32 млд
725,90 млн
990,25 млн
EBT excluding unusual items
1,22 млд
1,44 млд
727,99 млн
988,87 млн
Income tax expense
397,56 млн
194,58 млн
158,70 млн
348,00 млн
Effective tax rate
21,70%
14,78%
21,86%
35,14%
Other operating expenses
-
-
-
-
Net income
1,43 млд
1,12 млд
567,20 млн
642,25 млн
Net profit margin
30,07%
17,91%
6,56%
7,29%
Earnings per share
5,46
4,26
1,97
2,43
Interest and investment income
27,63 млн
31,75 млн
33,26 млн
28,46 млн
Interest expense
-123,20 млн
-489,98 млн
-1,21 млд
-1,21 млд
Net interest expenses
-95,58 млн
-458,22 млн
-1,17 млд
-1,18 млд
Depreciation and amortization charges
-
-
-
-
EBITDA
1,53 млд
2,21 млд
2,54 млд
2,92 млд
Gain or loss from assets sale
-702,00 миң
4,03 млн
2,09 млн
-1,38 млн
AI content may include mistakes. Learn more
Google колдонмолору